Microrna Signatures Predicting Responsiveness To Anti-her2 Therapy

Abstract

The invention provides miRNA signatures and methods of making and using thereof. MiRNA signatures determine the responsiveness of HER2 expressing breast tumors to anti-HER2 treatment, such as the targeted drug therapy trastuzumab.


Claims
Owners (US)

Download Citation


Sign in to the Lens

Feedback